K Pharma (4896) · PolicyRestated
Contribution to Sustainability in Health and Education Through Medical Innovation
First written in FY2023. 2 of 3 entries say "Restated". Latest entry: FY2025.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Sustainability Management, ESG, Materiality and Information DisclosureA theme 627 companies write about · 1 as a headwind · 658 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 184 companies compared. The sentences above are computed from all 184.Comparing 200 of the theme's 659 threads.Full recordFilings, disclosures and news, newest first
- FY2025RestatedAnnual report
「We are advancing our business so that our business activities and services contribute to achieving sustainability.」
The company reiterates its commitment to contributing to health, well-being and education through medical innovation. - FY2024RestatedAnnual report
「We are advancing our business so that our business activities and services contribute to achieving sustainability.」
The company reiterates its aim of contributing to health, well-being and education through medical innovation. - FY2023First statedAnnual report
「We are advancing our business so that our business activities and services contribute to achieving sustainability.」
The company links its business activities to the SDGs “Good Health and Well-Being” and “Quality Education.”